Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2005 3
2006 1
2007 2
2008 1
2010 1
2011 3
2012 3
2013 3
2014 4
2015 4
2016 2
2017 5
2018 4
2019 4
2020 5
2021 8
2022 5
2023 3
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
Sexual dimorphism and the multi-omic response to exercise training in rat subcutaneous white adipose tissue.
Many GM, Sanford JA, Sagendorf TJ, Hou Z, Nigro P, Whytock KL, Amar D, Caputo T, Gay NR, Gaul DA, Hirshman MF, Jimenez-Morales D, Lindholm ME, Muehlbauer MJ, Vamvini M, Bergman BC, Fernández FM, Goodyear LJ, Hevener AL, Ortlund EA, Sparks LM, Xia A, Adkins JN, Bodine SC, Newgard CB, Schenk S; MoTrPAC Study Group. Many GM, et al. Nat Metab. 2024 May 1. doi: 10.1038/s42255-023-00959-9. Online ahead of print. Nat Metab. 2024. PMID: 38693320
Targeting CCL2/CCR2 signaling overcomes MEK inhibitor resistance in Acute Myeloid Leukemia.
Modak RV, de Oliveira Rebola KG, McClatchy J, Mohammadhosseini M, Damnernsawad A, Kurtz SE, Eide CA, Wu G, Laderas T, Nechiporuk T, Gritsenko MA, Hansen JR, Hutchinson C, Gosline SJC, Piehowski P, Bottomly D, Short N, Rodland K, McWeeney SK, Tyner JW, Agarwal A. Modak RV, et al. Among authors: hansen jr. Clin Cancer Res. 2024 Mar 7. doi: 10.1158/1078-0432.CCR-23-2654. Online ahead of print. Clin Cancer Res. 2024. PMID: 38451486
Mapping the proteogenomic landscape enables prediction of drug response in acute myeloid leukemia.
Pino JC, Posso C, Joshi SK, Nestor M, Moon J, Hansen JR, Hutchinson-Bunch C, Gritsenko MA, Weitz KK, Watanabe-Smith K, Long N, McDermott JE, Druker BJ, Liu T, Tyner JW, Agarwal A, Traer E, Piehowski PD, Tognon CE, Rodland KD, Gosline SJC. Pino JC, et al. Among authors: hansen jr. Cell Rep Med. 2024 Jan 16;5(1):101359. doi: 10.1016/j.xcrm.2023.101359. Cell Rep Med. 2024. PMID: 38232702 Free PMC article.
Design and Synthesis of Novel Cereblon Binders for Use in Targeted Protein Degradation.
Norris S, Ba X, Rhodes J, Huang D, Khambatta G, Buenviaje J, Nayak S, Meiring J, Reiss S, Xu S, Shi L, Whitefield B, Alexander M, Horn EJ, Correa M, Tehrani L, Hansen JD, Papa P, Mortensen DS. Norris S, et al. Among authors: hansen jd. J Med Chem. 2023 Dec 14;66(23):16388-16409. doi: 10.1021/acs.jmedchem.3c01848. Epub 2023 Nov 22. J Med Chem. 2023. PMID: 37991844
Insights from a workplace SARS-CoV-2 specimen collection program, with genomes placed into global sequence phylogeny.
Leiser OP, Auberry DL, Bakker E, Chrisler W, Engbrecht K, Engelmann H, Fansler S, Gerbasi V, Hansen J, Hutchinson C, Hutchison J, Lancaster MJ, Lawrence K, Melville A, Mobberley J, O'Bryon I, Oxford KL, Oxford T, Phillips S, Rodda KE, Sanford JA, Schepmoes A, Staley BE, Terrell K, Victry K, Warner C, Omberg KM. Leiser OP, et al. Among authors: hansen j. PLoS One. 2023 Apr 28;18(4):e0285042. doi: 10.1371/journal.pone.0285042. eCollection 2023. PLoS One. 2023. PMID: 37115761 Free PMC article.
Pancreatic enzyme supplementation versus placebo for improvement of gastrointestinal symptoms in non-responsive celiac disease: A cross-over randomized controlled trial.
Yoosuf S, Barrett CG, Papamichael K, Madoff SE, Kurada S, Hansen J, Silvester JA, Therrien A, Singh P, Dennis M, Leffler DA, Kelly CP. Yoosuf S, et al. Among authors: hansen j. Front Med (Lausanne). 2023 Jan 4;9:1001879. doi: 10.3389/fmed.2022.1001879. eCollection 2022. Front Med (Lausanne). 2023. PMID: 36687454 Free PMC article.
Proteomic and phosphoproteomic measurements enhance ability to predict ex vivo drug response in AML.
Gosline SJC, Tognon C, Nestor M, Joshi S, Modak R, Damnernsawad A, Posso C, Moon J, Hansen JR, Hutchinson-Bunch C, Pino JC, Gritsenko MA, Weitz KK, Traer E, Tyner J, Druker B, Agarwal A, Piehowski P, McDermott JE, Rodland K. Gosline SJC, et al. Among authors: hansen jr. Clin Proteomics. 2022 Jul 27;19(1):30. doi: 10.1186/s12014-022-09367-9. Clin Proteomics. 2022. PMID: 35896960 Free PMC article.
56 results